Bylaws

We strive to provide a opportunity for diverse stakeholders to come together to support the advancement, exchange and application of new knowledge among leading researchers, educators, patient groups, government, industry representatives, academia and health practitioners interested in the use, economics and outcomes of medicinal drugs and other therapeutic interventions in populations.

To view the current Bylaws that guide the work of the organization: Bylaws

Please note that audited financial statements are presented at the Annual General Meeting and  are available upon request.